LifeMine Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
51
- Latest Deal Type
-
Series E
- Latest Deal Amount
-
$188M
- Investors
-
20
LifeMine General Information
Description
Developer of a drug discovery platform designed to elucidate human biology and create sophisticated therapeutics that attack the fundamental drivers of serious human diseases. The company's platform offers mining of fungal biodiversity to develop mechanistically and structurally novel therapeutics to address previously intractable therapeutic challenges, enabling healthcare providers to treat intractable human diseases via biological mechanisms.
Contact Information
Website
www.lifeminetx.comCorporate Office
- Cambridge Discovery Park
- 30 Acorn Park Drive
- Cambridge, MA 02140
- United States
Corporate Office
- Cambridge Discovery Park
- 30 Acorn Park Drive
- Cambridge, MA 02140
- United States
LifeMine Timeline
LifeMine Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC (Series E) | 06-Aug-2026 | $188M | Completed | Generating Revenue | ||
| 5. Secondary Transaction - Private | 01-Feb-2026 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series D) | 25-Sep-2025 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series C) | 01-Mar-2022 | Completed | Generating Revenue | |||
| 2. Later Stage VC (Series B) | 07-Jan-2021 | $50M | $125M | Completed | Startup | |
| 1. Early Stage VC (Series A) | 15-Sep-2017 | $75.1M | $75.1M | Completed | Startup |
LifeMine Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series E | ||||||||
| Series D | ||||||||
| Series C | ||||||||
| Series B | ||||||||
| Series A2 | 38,862,045 | $0.000100 | $0.93 | $0.93 | 1x | $0.72 | 5.61% | |
| Series A1 | 47,836,085 | $0.000100 | $0.76 | $0.76 | 1x | $0.61 | 6.56% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
LifeMine Comparisons
Industry
Financing
Details
LifeMine Competitors (42)
One of LifeMine’s 42 competitors is Snipr Biome, a Venture Capital-Backed company based in Copenhagen, Denmark.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Snipr Biome | Venture Capital-Backed | Copenhagen, Denmark | ||||
| Vedanta Biosciences | Venture Capital-Backed | Cambridge, MA | ||||
| Enterome | Venture Capital-Backed | Paris, France | ||||
| Eligo Bioscience | Venture Capital-Backed | Paris, France | ||||
| 4D pharma | Corporation | Leeds, United Kingdom |
LifeMine Patents
LifeMine Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026188020-A1 | Polymorphs of a triester compound and methods of use thereof | Pending | 06-Mar-2025 | ||
| WO-2026188020-A9 | Polymorphs of a triester compound and methods of use thereof | Pending | 06-Mar-2025 | ||
| US-20260176304-A1 | Novel cyclodepsipeptides and cyclopeptides and their use in therapy | Pending | 21-Nov-2024 | ||
| WO-2026112278-A1 | Novel cyclodepsipeptides and cyclopeptides and their use in therapy | Pending | 21-Nov-2024 | ||
| AU-2025258247-A1 | Tricyclic compounds and methods of use thereof | Pending | 17-Apr-2024 | C07D321/10 |
LifeMine Signals
LifeMine Investors (20)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Bezos Expeditions | Family Office | Minority | ||
| Explore Investments | Venture Capital | Minority | ||
| Gates Frontier | Venture Capital | Minority | ||
| RA Capital Management | Asset Manager | Minority | ||
| Lola Capital Partners | Venture Capital | Minority |
LifeMine FAQs
-
When was LifeMine founded?
LifeMine was founded in 2016.
-
Where is LifeMine headquartered?
LifeMine is headquartered in Cambridge, MA.
-
What is the size of LifeMine?
LifeMine has 51 total employees.
-
What industry is LifeMine in?
LifeMine’s primary industry is Drug Discovery.
-
Is LifeMine a private or public company?
LifeMine is a Private company.
-
What is the current valuation of LifeMine?
The current valuation of LifeMine is .
-
What is LifeMine’s current revenue?
The current revenue for LifeMine is .
-
How much funding has LifeMine raised over time?
LifeMine has raised $563M.
-
Who are LifeMine’s investors?
Bezos Expeditions, Explore Investments, Gates Frontier, RA Capital Management, and Lola Capital Partners are 5 of 20 investors who have invested in LifeMine.
-
Who are LifeMine’s competitors?
Snipr Biome, Vedanta Biosciences, Enterome, Eligo Bioscience, and 4D pharma are some of the 42 competitors of LifeMine.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process